ORMP - ORAMED PHARMACEUTICALS INC.
3.62
0.240 6.630%
Share volume: 163,978
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$3.38
0.24
0.07%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-14-2024 | 11-07-2024 | 03-27-2025 | 05-15-2025 | 08-14-2025 | 11-13-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 2.000 M | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 1.987 M | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 13.000 K | 0.000 | 0.000 | |
| nan% | nan% | nan% | -100.00% | nan% | ||||
| Operating expenses | 2.962 M | 3.135 M | 3.089 M | 3.595 M | 4.513 M | 2.489 M | 2.427 M | |
| Selling general and admin | 1.783 M | 1.693 M | 847.000 K | 2.134 M | 2.307 M | 1.455 M | 1.274 M | |
| Research and development | 1.179 M | 1.442 M | 2.242 M | 1.461 M | 2.206 M | 1.034 M | 1.153 M | |
| Total expenses | 2.962 M | 3.135 M | 3.089 M | 3.595 M | 4.513 M | 2.489 M | 2.427 M | |
| 5.84% | -1.47% | 16.38% | 25.54% | -44.85% | -2.49% | |||
| Operating income | -2.962 M | -3.135 M | -3.089 M | -3.595 M | -4.500 M | -2.489 M | -2.427 M | |
| Ebit | 2.126 M | 11.099 M | -18.509 M | -9.783 M | -7.058 M | 13.134 M | 59.451 M | |
| Pretax income | 1.534 M | 10.838 M | -18.509 M | -9.783 M | -7.058 M | 13.134 M | 59.451 M | |
| 606.52% | -270.78% | -47.14% | -27.85% | -286.09% | 352.65% | |||
| Income tax | 0.000 | 1.634 M | 1.133 M | 0.000 | 584.000 K | -126.000 K | 11.062 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 1.534 M | 9.204 M | -19.642 M | -10.156 M | -7.642 M | 13.260 M | 48.389 M | |
| 500.00% | -313.41% | 48.29% | 24.75% | 273.51% | 264.92% |